We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 642 results
  1. Sigmoid colon schwannoma difficult to distinguish from peritoneal dissemination 13 years after pancreatic neuroendocrine tumor surgery

    Background

    Schwannoma, which clinicians sometimes struggle to diagnose, is a tumor arising from Schwann cells of peripheral nerves, often in the soft...

    Kazunobu Suzuki, Takuya Shiraishi, ... Hiroshi Saeki in Surgical Case Reports
    Article Open access 11 May 2023
  2. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas

    Objective

    To identify quantitative CT features for distinguishing well-differentiated pancreatic neuroendocrine tumors (PNETs) from poorly...

    Hai-Yan Chen, Yao Pan, ... Guo-Liang Shao in European Radiology
    Article 27 June 2022
  3. A radiomics-based interpretable model to predict the pathological grade of pancreatic neuroendocrine tumors

    Objectives

    To develop a computed tomography (CT) radiomics-based interpretable machine learning (ML) model to predict the pathological grade of...

    **g-Yuan Ye, Peng Fang, ... **ao-Yu Yin in European Radiology
    Article Open access 02 September 2023
  4. Radiomics analysis from magnetic resonance imaging in predicting the grade of nonfunctioning pancreatic neuroendocrine tumors: a multicenter study

    Objectives

    To explore the potential of radiomics features to predict the histologic grade of nonfunctioning pancreatic neuroendocrine tumor (NF-PNET)...

    Hai-Bin Zhu, Hai-Tao Zhu, ... Ying-Shi Sun in European Radiology
    Article Open access 08 August 2023
  5. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States

    Purpose

    The incidence of pancreatic neuroendocrine tumors (pNETs) was increasing. The main purpose of this study was to statistically analyze the...

    X. Liu, B. Chen, ... S. Sun in Journal of Endocrinological Investigation
    Article 15 December 2022
  6. Long-Term Oncologic Outcome following Duodenum-Preserving Pancreatic Head Resection for Benign Tumors, Cystic Neoplasms, and Neuroendocrine Tumors: Systematic Review and Meta-analysis

    Background

    Pancreatoduodenectomy (PD) has a considerable surgical risk for complications and late metabolic morbidity. Parenchyma-sparing resection of...

    Hans G. Beger, Benjamin Mayer, Bertram Poch in Annals of Surgical Oncology
    Article Open access 05 April 2024
  7. Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study

    Background

    We sought to define the accuracy of preoperative imaging to detect lymph node metastasis (LNM) among patients with pancreatic...

    Nan Zhang, ** He, ... Timothy M. Pawlik in Annals of Surgical Oncology
    Article 14 December 2023
  8. The association between jaundice and poorly differentiated pancreatic neuroendocrine neoplasms (Ki67 index > 55.0%)

    Background

    Jaundice occurs in some pancreatic disease. However, its occurrences and role in pancreatic neuroendocrine neoplasms (PNENs) has not been...

    Yongkang Liu, Jiangchuan Wang, ... **ao Chen in BMC Gastroenterology
    Article Open access 12 December 2023
  9. Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study

    Introduction

    Approval of sunitinib and everolimus for the treatment of progressive, unresectable or metastatic well-differentiated pancreatic...

    Denis Smith, Côme Lepage, ... Catherine Lombard-Bohas in Advances in Therapy
    Article Open access 13 April 2022
  10. Tumor-to-tumor metastasis: an extremely rare combination with renal cell carcinoma as the donor and a pancreatic neuroendocrine tumor as the recipient

    Background

    Tumor-to-tumor metastasis is a rare phenomenon in which primary tumor cells metastasize hematogenously into another tumor. Herein, we...

    Shunryo Minezaki, Takeyuki Misawa, ... Hiroshi Kondo in Surgical Case Reports
    Article Open access 10 January 2022
  11. Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors

    Background

    Radiographic calcifications and cystic morphology are associated with higher and lower tumor grade, respectively, in pancreatic...

    Eleftherios A. Makris, John G. Douglas Cannon, ... George A. Poultsides in Annals of Surgical Oncology
    Article 25 November 2022
  12. Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors

    Background

    Approximately 40–50% of patients with pancreatic neuroendocrine tumors (pNETs) initially present with distant metastases. Little is known...

    Hallbera Gudmundsdottir, Ron Pery, ... Sean P. Cleary in Annals of Surgical Oncology
    Article Open access 22 June 2022
  13. Preoperative prediction of lymph node metastasis in nonfunctioning pancreatic neuroendocrine tumors from clinical and MRI features: a multicenter study

    Background

    The extent of surgery in nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs) has not well established, partly owing to the dilemma...

    Hai-bin Zhu, Pei Nie, ... Ying-Shi Sun in Insights into Imaging
    Article Open access 08 October 2022
  14. Role of Endoscopic Ultrasound Ablative Therapy in Management of Pancreatic Neuroendocrine Tumors: a Systematic Review

    Pancreatic neuroendocrine tumors (PNET) represent less than 3% of all primary pancreatic tumors. With the advent of advanced imaging techniques...

    Bharath S, Ashutosh Carpenter, ... Dhananjaya Sharma in Indian Journal of Surgery
    Article 29 November 2022
  15. The association between non-HDL cholesterol and high-grade pancreatic neuroendocrine neoplasms

    Purpose

    High-density lipoprotein cholesterol (HDL-c) plays an important role in tumorigenesis in several endocrine-related cancers. Few studies have...

    Hao Zhou, Yong Zhu, ... **ao Chen in Endocrine
    Article 06 June 2024
  16. Usefulness of intratumoral perfusion analysis for assessing biological features of non-functional pancreatic neuroendocrine neoplasm

    Purpose

    Here, we evaluated the usefulness of intratumoral perfusion analysis using preoperative contrast-enhanced CT (E-CT) to assess biological...

    Tsuyoshi Notake, Akira Shimizu, ... Yuji Soejima in Langenbeck's Archives of Surgery
    Article 15 January 2024
  17. Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Map**

    Introduction

    There is a paucity of effective treatment options for advanced pancreatic neuroendocrine tumors (pNETs). Genome-wide analyses may allow...

    Yao **ao, Gang Xu, ... Timothy M. Pawlik in Journal of Gastrointestinal Surgery
    Article 04 May 2022
  18. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors

    Background

    Although some factors that predict the prognosis in pancreatic neuroendocrine tumor (pNET) have been confirmed, the predictive value of...

    Zheng Zhang, Fei Wang, ... Shunrong Ji in BMC Surgery
    Article Open access 10 May 2022
  19. Survival Benefit of Primary Tumor Resection Among Elderly Patients with Pancreatic Neuroendocrine Tumors

    Background

    Pancreatectomy is the main curative therapeutic option for pancreatic neuroendocrine tumors (pNETs). Given the indolent behavior of pNETs...

    Junya Toyoda, Kota Sahara, ... Timothy M. Pawlik in World Journal of Surgery
    Article 11 August 2021
  20. Maximum Value on Arterial Phase Computed Tomography Predicts Prognosis and Treatment Efficacy of Sunitinib for Pancreatic Neuroendocrine Tumours

    Purpose

    This study was designed to assess the computed tomography maximum (CTmax) value on pretherapeutic arterial phase computed tomography (APCT)...

    Haidi Chen, Zheng Li, ... Shunrong Ji in Annals of Surgical Oncology
    Article 30 October 2022
Did you find what you were looking for? Share feedback.